Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart.
Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators. Marchioli R, et al. Eur Heart J. 2001 Nov;22(22):2085-103. doi: 10.1053/euhj.2000.2544. Eur Heart J. 2001. PMID: 11686666 Clinical Trial.
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Macchia A, Levantesi G, Franzosi MG, Geraci E, Maggioni AP, Marfisi R, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Macchia A, et al. Among authors: marchioli r. Eur J Heart Fail. 2005 Aug;7(5):904-9. doi: 10.1016/j.ejheart.2005.04.008. Eur J Heart Fail. 2005. PMID: 16087142 Free article.
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
Franzosi MG, Brunetti M, Marchioli R, Marfisi RM, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators. Franzosi MG, et al. Among authors: marchioli r. Pharmacoeconomics. 2001;19(4):411-20. doi: 10.2165/00019053-200119040-00008. Pharmacoeconomics. 2001. PMID: 11383757
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators. Tavazzi L, et al. Among authors: marchioli r. Eur J Heart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. Eur J Heart Fail. 2004. PMID: 15302013 Free article. Clinical Trial.
Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Levantesi G, et al. Among authors: marchioli r. J Am Coll Cardiol. 2005 Jul 19;46(2):277-83. doi: 10.1016/j.jacc.2005.03.062. J Am Coll Cardiol. 2005. PMID: 16022955 Free article. Clinical Trial.
[Determinants of late-onset heart failure in myocardial infarction survivors: GISSI Prevenzione trial results].
Macchia A, Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; Investigadores del estudio Grupo Italiano para el Estudio de la Supervivencia en el Infarto de Miocardio Prevenzione. Macchia A, et al. Among authors: marchioli r. Rev Esp Cardiol. 2005 Nov;58(11):1266-72. Rev Esp Cardiol. 2005. PMID: 16324579 Free article. Spanish.
189 results